Phenytoin kinetics in children

Area of Science:

• Pharmacology
• Pediatric Medicine
• Clinical Pharmacy

Background:

• Phenytoin is an antiepileptic drug commonly prescribed for infants and children.
• Understanding drug concentration variability is crucial for optimizing therapeutic efficacy and minimizing toxicity in pediatric populations.
• Nonlinear elimination kinetics can lead to unpredictable serum drug levels if not properly managed.

Purpose of the Study:

• To investigate the pharmacokinetic profile of oral phenytoin in pediatric patients.
• To assess the variability of serum phenytoin levels over a 12-hour dosing interval.
• To correlate average serum phenytoin concentrations with the degree of fluctuation.

Main Methods:

• Serum phenytoin levels were measured in infants and children at 4-hour intervals after oral administration every 12 hours.
• Pharmacokinetic parameters, including serum level fluctuations, were analyzed.
• The relationship between average drug levels and variability was examined.

Main Results:

• Pediatric patients exhibited relatively small fluctuations in serum phenytoin levels when dosed every 12 hours.
• Increased average serum phenytoin concentrations were associated with reduced relative fluctuations.
• Serum levels measured 8 hours post-dose demonstrated the least variability, averaging 104% of the 12-hour mean.

Conclusions:

• Oral phenytoin dosing every 12 hours in children results in manageable serum level variability.
• The observed reduction in fluctuation with higher average levels supports nonlinear elimination kinetics for phenytoin in this population.
• Targeting specific post-dose measurement times, such as 8 hours, may provide a representative assessment of therapeutic phenytoin levels in pediatric patients.